Cargando…
Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasive fungal disease in South America. Systemic mycoses are the 10th most common cause of death among infectious diseases in Brazil and PCM is responsible for more than 50% of deaths due to fungal infecti...
Autores principales: | Rittner, Glauce M. G., Muñoz, Julián E., Marques, Alexandre F., Nosanchuk, Joshua D., Taborda, Carlos P., Travassos, Luiz R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289603/ https://www.ncbi.nlm.nih.gov/pubmed/22389734 http://dx.doi.org/10.1371/journal.pntd.0001519 |
Ejemplares similares
-
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
por: Silva, Leandro B. R., et al.
Publicado: (2017) -
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide
por: Mayorga, Oriana, et al.
Publicado: (2012) -
Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice
por: Silva, Leandro B. R., et al.
Publicado: (2019) -
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE
AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
por: TABORDA, Carlos. P., et al.
Publicado: (2015) -
Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis
por: Santos, Suelen S., et al.
Publicado: (2023)